Centogene announces approval of all resolutions tabled at 2023 annual general meeting

Cambridge, mass. and rostock, germany and berlin, june 30, 2023 (globe newswire) -- centogene n.v. (nasdaq: cntg) (the “company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the voting results of the company's annual general meeting. shareholders voted in favor of all proposals, which included the appointment of prof. dr. peter bauer as a member of the management board of the company, as well as the appointment of mary sheahan and the reappointment of peer schatz as members of the supervisory board of the company.
CNTG Ratings Summary
CNTG Quant Ranking